| Authors: |
Castillo JJ; Bing Center for Waldenström Macroglobulinemia, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA. Electronic address: jorgej_castillo@dfci.harvard.edu., Autore F; Institute of Hematology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., Berinstein NL; Odette Cancer Centre, Sunnybrook Research Institute, Toronto, Canada., Branagan AR; Division of Hematology and Oncology, Massachusetts General Hospital, Boston, MA., Dimopoulos MA; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece., Fernandez de Larrea C; Department of Hematology, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain., Ferrero S; Department of Molecular Biotechnologies and Health Sciences, Division of Hematology, University of Torino, Torino, Italy., Kapoor P; Division of Hematology, Mayo Clinic, Rochester, MN., Kastritis E; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece., Khwaja J; Department of Haematology, University College London Hospital, London, United Kingdom., Minnema MC; Department of Hematology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Qiu L; National Clinical Research Center for Hematological Diseases, State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China., Seymour JF; Peter MacCallum Cancer Centre, Royal Melbourne Hospital and University of Melbourne, Melbourne, Victoria, Australia., Vos JMI; Department of Hematology, Amsterdam University Medical Center (A-UMC), University of Amsterdam, Amsterdam, The Netherlands., Patterson CJ; Bing Center for Waldenström Macroglobulinemia, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA., Buske C; Comprehensive Cancer Center Ulm, Institute of Experimental Cancer Research, University Hospital Ulm, Ulm, Germany., Matous JV; Plasma Cell Diseases Group Colorado Blood Cancer Institute, Sarah Cannon Research Institute, Denver, CO., Treon SP; Bing Center for Waldenström Macroglobulinemia, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA., Palomba ML; Lymphoma Service, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY. |
